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Alcoholic liver disease (ALD) is a multifaceted disease that is characterized by hepatic steatosis or fat deposition and hepatitis or
inflammation. Over the past decade, multiple lines of evidence have emerged on the mechanisms associated with ALD. The key
mechanisms identified so far are sensitization to gut-derived endotoxin/lipopolysaccharide resulting in proinflammatory cytokine
production and cellular stress due to oxidative processes, contributing to the development and progression of disease. While
oxidative stress and inflammatory responses are studied independently in ALD, mechanisms linking these two processes play a
major role in pathogenesis of disease. Here we review major players of oxidative stress and inflammation and highlight signaling
intermediates regulated by oxidative stress that provokes proinflammatory responses in alcoholic liver disease.
1. Introduction
The pathogenesis of alcoholic liver disease (ALD) is a conse-
quence of chronic alcohol abuse and approximately 44% of
the 26,000 deaths from cirrhosis are due to ALD in the United
States [1]. Alcoholic hepatitis, the clinical presentation of
ALD, remains to be a common life threatening cause of
liver failure, especially when it is severe. Chronic alcohol
consumption has long been associated with progressive
liver disease from steatosis to inflammation, development
of hepatic cirrhosis, and the subsequent increased risk of
hepatocellular carcinoma. Several studies have attempted to
identify the molecular pathways, direct or indirect, aﬀected
by alcohol exposure in the liver. These pathways range
from oxidative stress, metabolism-related eﬀects, and inflam-
mation to apoptosis. Induction of oxidative stress and
activation of the inflammatory cascade are identified as key
elements in the pathophysiology of ALD [2]. While these
intracellular mechanisms aﬀected by alcohol are studied
exclusively, the interplay of signaling molecules between
pathways leading to alcoholic liver disease has received less
attention. Unraveling these interactions of oxidative stress
mediators and inflammatory signaling in the liver will aid
in identification of new integrative approaches as it relates
to alcoholic liver injury and provide potential new directions
to develop therapeutic target intervention. The goal of this
concise paper is to first review alcohol-induced reactive
oxygen species and oxidative stress generated by alcohol
metabolism, endoplasmic reticulum stress, mitochondrial
ROS in the liver, protein adduct formation, and autophagy
and chaperone function and then to describe stress-mediated
activation of receptors, kinases, and transcription factors
resulting in proinflammatory signaling in ALD.
2. Classical Mechanisms of
Alcoholic Liver Disease
Research done, so far, on the eﬀects of pathophysiological
mechanisms of alcoholic liver disease suggests the involve-
ment of two main liver cell types, resident macrophages, or
Kupﬀer cells and hepatocytes. The role of gut-derived endo-
toxin and liver macrophage activation is clearly established in
ALD by Thurman and colleagues [2]. The deleterious eﬀects
of alcohol, attributed to its metabolism, primarily occur
in hepatocytes [3]. Alcohol metabolism pathway including
induction of cytochrome P450 2E1 [3] results in adduct
formation and generation of reactive oxygen radicals respec-
tively creating an oxidative microenvironment and damage
in the liver [2]. In the currently accepted model of ALD,
chronic alcohol induces oxidative stress and sensitization
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to endotoxin, which activates the CD14/TLR4 pathway and
downstream signaling resulting in proinflammatory cytokine
production [4]. The proinflammatory cytokines, particularly
TNFα, then provoke hepatocellular injury and death by
extrinsic, via TNFR1 [5] and intrinsic death pathways [6]
leading to ALD. While the role of oxidative stress and
macrophage activation, the two main pathophysiological
processes aﬀected in ALD, were studied independently in
the past, recent studies suggest that these pathways are
interconnected in ALD improving our understanding of the
disease.
3. Reactive Oxygen Species (ROS) and Alcohol
While activation of inflammatory responses are central
to alcoholic liver injury, excessive generation of reactive
oxygen species plays an equally significant role in alcohol-
induced cellular damage [7]. Alcohol-induced liver disease is
associated with a state of “oxidative stress”. The metabolism
of alcohol by alcohol dehydrogenase [ADH] leads to for-
mation of acetaldehyde. Further, the acetaldehyde is metab-
olized to acetate by acetaldehyde dehydrogenase [ALDH].
Acetaldehyde, a reactive intermediate has an ability to form
adducts with DNA [8, 9]. Whether acute or chronic, alco-
hol metabolism increases production of acetaldehyde and
enhances formation of DNA adducts leading to tissue injury.
On the other hand, metabolism of alcohol via cytochrome
P4502E1 induces production of reactive oxygen species
which facilitates adduct formation, activates stress proteins,
induces endoplasmic reticulum stress, and aﬀects lysosomal
function and autophagy leading to mitochondrial injury and
hepatocellular death.
3.1. Alcohol Metabolism and ROS. Ethanol is primarily meta-
bolized in the liver by oxidative enzymatic pathways. The
classical pathway of alcohol metabolism involves enzymatic
breakdown of alcohol by the enzyme, alcohol dehydrogenase
(ADH) and its subsequent conversion to acetaldehyde and
formation of acetate. ADH is predominantly expressed in
liver [10] but other tissues like gastric mucosa express ADH
and contribute to metabolism of alcohol [10]. Aldehyde
dehydrogenase (ALDH) contributes to oxidation of aldehyde
intermediates resulting in acetate which is unstable and
breaks down to water and carbon dioxide. The second
major pathway for ethanol degradation is the microsomal
system catalyzed by cytochrome P450 enzymes. The 2E1
isoform of the cytochrome P450 (CYP2E1) system is induced
during chronic alcohol consumption. Activation of CYP2E1
leads to ROS generation and highly reactive free radicals
including superoxide anions and hydroxyl radicals resulting
in oxidative stress and cell death [11]. The role of CYP2E1
in hepatocyte injury has been elucidated using HEPG2
cells overexpressing CYP2E1 [12], CYP2E1 knockout mice,
and transgenic mice [13]. Increased oxidative stress from
induction of CYP2E1 in vivo sensitizes hepatocytes to
LPS and TNFα toxicity [14] and CYP2E1 knock-in mice
showed elevated hepatic steatosis and liver injury after
alcohol feeding [13]. On the other hand, CYP2E1 knockout
mice showed decreased oxidant stress, upregulation of
PPARα and were protective to alcohol-induced liver injury.
Peroxynitrite, activation of p38 and JNK MAP kinases,
and mitochondrial dysfunction are downstream mediators
of the CYP2E1-LPS/TNF potentiated hepatotoxicity [15].
Oxidation of ethanol by alcohol dehydrogenase and sub-
sequent metabolism of acetaldehyde results in increased
NADH/NAD+ ratio in the cytoplasm and mitochondria
[16]. The increase in NADH results in inhibition of mito-
chondrial β-oxidation and accumulation of intracellular
lipids [17]. Alcohol/CYP2E1-mediated ROS has the potential
to peroxidize lipids and inhibit mitochondrial and peroxiso-
mal β-oxidation enzymes such as acyl-CoA dehydrogenases,
carnitine palmitoyl transferase-1 (CPT-1), and peroxisomal
proliferator-inducing pathways, respectively [18]. This dis-
ruption leads to increased fatty acids, substrates of these
enzymes, and their accumulation resulting in development
of hepatic steatosis. Oxidative stress and ROS generation due
to alcohol metabolism not only increase accumulation of
lipids in hepatocytes but also sensitize the liver to subsequent
insults by cytokines.
3.2. Mitochondria and Oxidative Stress. In mitochondria,
ROSs are generated as undesirable side products of the
oxidative energy metabolism. An excessive and/or sustained
increase in ROS production has been implicated in the
pathogenesis of ALD, ischemia/reperfusion injury, and other
diseases [19]. Oxidative stress induced by alcohol is closely
associated with alterations in mitochondrial function result-
ing in cellular death. Hepatic mitochondria either acutely
or chronically exposed to ethanol generate increased levels
of reactive oxygen species (ROS) [20]. The induction of
mitochondrial dysfunction is also linked to the metabolism
of alcohol by CYP2E1 and increased oxidative stress [11].
Primary hepatocytes and rat hepatoma cells when treated
with ethanol led to an increase in ROS/RNS and loss of
mitochondrial function due to damagedmitochondrial DNA
and ribosomes and subsequent inhibition of mitochondrial
protein synthesis [21, 22]. Studies have shown that alcohol-
induced ROS generation leads to alteration in mitochondrial
membrane permeability and transition potential that in
turn initiates the release of proapoptotic factors such as
cytochrome c [21]. Transition of mitochondrial permeability
results in increased caspase-3 activation in hepatocytes and
this depends on p38 MAPK activation but is independent
of caspase-8 [5]. Various studies show that decreased ATP
synthesis accompanied by reduced mitochondrial protein
synthesis, inhibition of the oxidative phosphorylation system
(OxPhos), and damage to mitochondrial DNA leads to
dysfunctional mitochondria and oxidative stress in alcoholic
liver disease [23]. Peroxisome proliferator activated receptor
gamma (PPARγ)-coactivator 1 alpha (PGC-1α), a transcrip-
tion coactivator involved in mitochondrial biogenesis, is
involved in defenses against ROS by inducing many ROS-
mediated detoxifying enzymes. PGC-1 gene expression was
lower in hepatic tissues of rats exposed to ethanol [24].
In vitro exposure of hepatoma cells to 500mM ethanol
significantly decreased hepatic SIRT-1; PGC-1α leads to
ROS-inducedmitochondrial and cellular injury [25]. Certain
sirtuins, a family of protein deacetylases, were found to
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regulate glucose and fat metabolism in mammals [26, 27]
and to enhance mitochondrial biogenesis in liver and muscle
through PGC-1α and to influence cell survival [28].
Recent studies used an antioxidant peptide targeted
to mitochondria to show that altered ROS metabolism
facilitates enhanced expression of HIF-1alpha [29], which, in
turn, increases TNF-alpha secretion. These findings provide
in vivo evidence for the action of mitochondrial ROS on
HIF-1alpha activity and demonstrate that changes in mito-
chondrial function within physiologically tolerable limits can
modulate the immune response [29]. These studies suggest
that alcohol-induced mitochondrial stress pathways set the
stage for proinflammatory cytokine-induced cell death and
liver injury.
3.3. Protein Adducts and Lysosomal Dysfunction. Alcohol
metabolism and oxidative stress result in the formation of
reactive aldehydes such as acetaldehyde, malondialdehyde
(MDA), and 4-hydroxy-2-nonenal (HNE) that can bind to
proteins to form adducts [30]. In vivo models of chronic
alcohol consumption have shown that acetaldehyde, MDA,
and HNE adduct formation are increased in various organs
including the liver [30]. A strong corelation between 4-
HNE adducts and expression of CYP2E1 in patients with
ALD was recently shown [31]. Acetaldehyde and MDA react
with proteins synergistically to form hybrid protein adducts
called malondialdehyde-acetaldehyde (MAA) adducts [32].
Recognition of MAA-adducts by Kupﬀer cells, endothelial,
and stellate cells via the scavenger receptor resulted in upreg-
ulation of cytokine and chemokine production and increased
expression of adhesion molecules [32]. Circulating antibod-
ies to MAA-adducts were detected in patients with alcoholic
hepatitis and cirrhosis and correlated with the severity
of liver injury [33]. Chronic alcohol feeding also induces
formation of gamma-ketoaldehyde protein adducts in mouse
livers [34]. These adducts are formed in a TNFR1/CYP2E1
dependent, but cyclooxygenase-independent manner in
mouse liver [34]. Existence of protein adducts during chronic
alcohol consumption and their identification in animal
models has been challenging, limiting investigation of their
precise role in ALD.
Increased ROS and lipid peroxidation rate in microsomal
and lysosomal membranes with a simultaneous decrease
in the levels of glutathione sulfhydryls and glutathione-S-
transferase activity was observed during alcohol exposure
[35]. Elevation of cathepsin B in hepatic cytosol fractions,
indicating lysosomal leakage, was reported in ethanol-fed
rats [36]. Lysosomal leakage was increased in alcohol-fed
mice deficient in superoxide dismutase (SOD) indicating that
oxidative stress correlated with loss of lysosomal function
increased hepatic fat and inflammatory cell infiltration
[37]. The exact mechanisms responsible for ethanol-induced
changes in lysosomal function are not clear but there is
evidence of enhanced lysosomal membrane fragility, which
could result from either altered lipid peroxidation, oxidative
stress, or both [38]. More recently, degradation of a cell’s
own cytosolic components in the lysosomes as a protective
mechanism against the damaging eﬀects of oxidative stress
has been described and is termed autophagy [38]. Alcoholic
liver injury is associated with decreased autophagy result-
ing in accumulation of damaged proteins and liver cell
death [38]. Recent studies show that macro-, micro- and
chaperone-mediated autophagy is linked to innate and
adaptive immune responses [39]. While autophagy acts as
an eﬀector and regulator of pattern recognition receptors
including TLR4 signaling in macrophages, loss or defective
autophagy results in accumulation of cytosolic components
and chronic inflammatory responses [40]. How loss of
autophagy after chronic alcohol consumption contributes to
proinflammatory responses in alcoholic liver disease remains
to be investigated.
3.4. Endoplasmic Reticulum (ER) Stress. The unfolded pro-
tein response (UPR) is a protective response of the cell also
referred to as the ER stress response during pathological
conditions. In alcoholic liver disease, increased expression
of glucose regulatory protein (GRP)78, GRP94, CHOP,
and caspase-12 indicated a UPR/ER stress response [41].
Upregulation and activation of ER-localized transcription
factors such as SREBP-1c and SREBP-2 were associated
with increased lipid accumulation and induction of fatty
liver during chronic alcohol exposure [42]. Another impor-
tant inducer of ER stress, homocysteine, was increased in
alcoholic human subjects leading to hyperhomocysteinemia,
also observed in alcohol feeding rodent models [43]. The
role of ER stress in triglyceride accumulation and fatty
liver comes from studies showing that betaine increases an
enzyme, betaine homocysteine methyltransferase (BHMT)
and reduces homocysteine levels to inhibit lipid accumula-
tion [43]. Recent studies suggest that ER/UPR stress path-
ways intersect with innate immune signaling determining the
duration and intensity of inflammatory response [44]. Addi-
tional mechanistic studies to link ER/UPR stress and innate
immune responses as a pathophysiological contributor in
ALD are warranted.
3.5. Alcohol, Stress, and Molecular Chaperones. Stress or heat
shock proteins (hsps) are ubiquitous and highly conser-
ved proteins, functioning as molecular chaperones, whose
expression is induced by oxidative stress stimuli and in
response to accumulation of unfolded cellular proteins.
Oxidative stress induces heat shock proteins via activation
of the heat shock transcription factor (HSF) [45]. Male
Wistar rats fed with acute as well as chronic alcohol showed
induction of hsp70 in the various regions of the brain and
the liver [46, 47]. However, the intensity of induction of
hsp70 in the liver, the principal organ of ethanol oxidation,
was much lower than the hippocampus or striatal areas
of the brain [47]. Hsp90 levels, on the other hand, were
increased in cultured rat hepatocytes exposed to acute
alcohol [47, 48]. Acute and chronic alcohol treatment of
monocytes/macrophages showed alterations in hsp70 and
hsp90 mRNA and protein levels based on the length of
alcohol exposure [49]. Acute alcohol induces HSF and
hsp70, whereas chronic alcohol induces hsp90 but not hsp70
protein, through activation of HSF [49]. Hsp90 functions as
a molecular chaperone controlling activity of various kinases
and signaling molecules of the LPS signaling pathway such
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as CD14 [50], IKK [51], and IRAK [52]. Comprehensive
studies on the eﬀect of acute and chronic alcohol exposure
on chaperone function of hsps in inflammatory responses in
the alcoholic liver could provide novel mechanistic insights
in ALD.
4. Inflammatory Response and ALD
Extensive studies over the past two decades have identified
the importance of macrophage activation in the liver by
gut-derived endotoxin after prolonged alcohol consump-
tion [2]. Central to this activation is the sensitization of
macrophages due to alcohol exposure and is associated with
mechanisms ranging from upregulation and engagement
of surface receptors on innate immune cells, intracellular
kinases and transcription factors contributing to induction
of proinflammatory cytokines.
4.1. Pattern Recognition Receptors, Alcohol, and Immune Cells.
Pattern recognition receptors (PRRs) are expressed on liver
nonparenchymal and parenchymal cells and function as sen-
sors of microbial danger signals enabling the vertebrate host
to initiate an immune response. The complexity of cellular
expression of PRRs in the liver provides unique aspects to
pathogen recognition and tissue damage in the liver [53].
Toll-like receptors (TLRs) that are membrane associated
or endosomal recognize distinct microbial components and
activate diﬀerent signaling pathways by selective utilization
of adaptor molecules [54]. TLRs such as TLR4 and TLR2
that detect PAMPs like LPS and lipoproteins, respectively,
are located on the cell surface whereas; TLRs such as TLR3,
TLR7, and TLR9 that detect viral RNA and DNA are located
in the endosome [55]. The pivotal role of TLR4 as well as
other TLRs has been extensively studied in alcoholic tissue
injury [56–59].
The interaction of oxidative stress and TLR signaling is
emerging. TLR4 is capable of inducing ROS leading to oxida-
tive stress [59–61]. Kupﬀer cells or hepatic macrophages pro-
duce reactive oxygen species (ROS) in response to antigenic
stimuli and chronic alcohol exposure as well as endotoxin
[62, 63]. Alcohol-induced sensitization of macrophages to
LPS has been attributed to ROS production [59, 60, 64].
Previous studies fromNagy and colleagues [64, 65] also show
that chronic ethanol feeding increases the sensitivity of Kupf-
fer cells to lipopolysaccharide (LPS), leading to increased
tumor necrosis factor alpha (TNFα) expression. NADPH
oxidase and ROS generation exhibit direct interaction with
the TLR4 receptor and activation of down-stream kinases
and transcription factors [61]. Studies by Gustot et al. [59]
show that oxidative stress regulates TLR 2, 4, 6, and 9
mRNA expression in alcoholic liver. Thus, it appears that
TLR mRNA, protein expression, and immune signaling can
be strongly influenced by oxidative stress in ALD making
these two events dependent on each other and not mutually
exclusive. Besides ROS, TLRs also mediate responses to host
molecules including intracellular mediators [66]. Amongst
the well-characterized DAMPs, high-mobility group box
1 (HMGB1), S100 proteins, hyaluronan, and heat shock
protein 60 (hsp60) are known to be recognized by TLR2 and
TLR4 [66, 67]. In addition, necrotic or apoptotic cells are also
recognized as DAMPs by TLRs [67]. In alcoholic liver injury,
apoptotic bodies, generated due to alcohol-induced oxidative
stress, could be recognized by DAMPs [68] and contribute to
inflammatory responses in the liver.
Activation of TLR4 recruits IRAK-1 to the TLR4 complex
via interaction with MyD88 and IRAK-4 [69]. The role of
MyD88, the common TLR4 adaptor molecule, was evaluated
in a mouse model of alcoholic liver injury [60]. These
studies showed that MyD88 knockout mice were highly
susceptible to alcohol-induced fatty liver [60]. While alcohol
feeding in TLR4 deficient mice prevented activation of
NADPH oxidase, alcohol-fed MyD88 deficient mice showed
high NADPH oxidase activity and increased oxidative stress
resulting in liver injury [60].
Increasing evidence suggests that downstream signaling
components activated by TLRs as well as cytokines and
chemokines produced can be regulated by oxidative stress
pathways. These interactions of stress pathways leading to
inflammation could contribute largely to initiation and
perpetuation of alcohol-related injury in the liver. The cross-
talk of stress regulated intracellular molecules with TLRs,
intracellular kinases and transcription factors resulting in
alterations in cytokines/chemokines in ALD are of great
importance.
4.2. MAPKs and IKKs. LPS/TLR4-induced ROS activation
[61] plays an important role in activation of downstream
signaling molecules such as IRAK1/4, TRAF6 leading to
activation of MAP kinases and NFκB during chronic
alcohol exposure [69]. Mitogen-activated protein kinase
[MAPK] signaling cascade plays an essential role in several
cellular processes including proliferation, diﬀerentiation,
and apoptosis. Acute alcohol exposure results in activa-
tion of baseline p42/44 MAPK in hepatocytes [70] while
chronic alcohol exposure causes potentiation of endotoxin-
stimulated p42/44 MAPK, and p38 MAPK signaling in
Kupﬀer cells leading to increased synthesis of TNFα [71,
72]. LPS stimulation of Kupﬀer cells in vitro exposed to
chronic alcohol in vivo exhibited increased p38 activity and
decreased JNK activity [71, 73]. Inhibition of p38 activation
impaired alcohol-mediated stabilization of TNFα mRNA
likely via interaction with tristetraprolin (TTP) [74]. On the
other hand, ERK1/2 inhibition did not alter TNFα mRNA
stability but aﬀectedmRNA transcription in chronic alcohol-
exposed macrophages via Egr-1 binding to the promoter
[75]. Whether alcohol-induced ROS plays a role in MAPK
activation in ALD is not yet determined.
TLR4-induced MyD88-dependent and independent
pathways lead to IKK kinase activation resulting in proin-
flammatory cytokine production [71]. Oxidative stress and
ROS-mediated molecular chaperones such as hsp90 are
shown to facilitate IKK kinase activity and downstream
NFκB nuclear activation [51]. Studies show that chronic
alcohol-induced NFκB activation in macrophages is due to
increased hsp90 resulting in elevated IKK kinase activity
[49]. Inhibition of hsp90 in chronic alcohol-exposed macro-
phages resulted in decreased IKK kinase activity and NFκB
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binding suggesting a cross-talk between cellular stress and
inflammatory pathways [49].
4.3. Transcription Factors in ALD. The transcription fac-
tor NFκB is a ubiquitous transcription factor that can
be activated by a large number of extracellular stimuli
such as cytokines, chemokines, growth factors, and bac-
terial or viral products [76]. NFκB activation triggers the
induction of inflammatory genes and plays an important
role in initiation and progression of alcoholic liver dis-
ease [69, 77]. While TLR-mediated activation of NFκB is
well established, ROS-induced activation of NFκB occurs
but remains poorly understood. Chronic alcohol exposure
induces LPS/TLR4-mediated NFκB activation in human
monocytes and macrophages contributing to production
of proinflammatory cytokine, TNFα [77]. Whether ROS
mediates activation of NFκB directly during ALD is unclear.
TLR4-induced MyD88-independent signaling leads to acti-
vation of IKKε and interferon regulatory factor 3 (IRF3) and
downstream Type I IFN activation [78, 79]. Previous studies
show that ROS mediates LPS-induced IRF3 activation [80].
Investigators found that IRF3 binds to the TNFα promoter
in macrophages after chronic alcohol administration [81]
and induces TNFα production. Whether alcohol-induced
ROS mediates IRF3 induction to increase proinflammatory
cytokines and liver injury needs further investigation.
Alcohol-mediated fatty liver injury is associated with
increased expression of genes regulating fatty acid synthesis
and suppression of genes involved in fatty acid oxidation
[82]. Transcription factors like SREBP and PPARα play a
pivotal role in fatty acid metabolism and rodent models
as well as in vitro treatment studies with alcohol show
downregulation of PPARα mRNA [83]. Further, DNA-
binding activity of PPARα is significantly reduced resulting
in decreased expression of target genes involved in fatty acid
metabolism after alcohol exposure [83]. Decreased PPARα
activity was accompanied by increased oxidative stress in the
liver resulting in increased sensitization of TNFα-induced
liver injury [83].
Another transcription factor, STAT3, in alcoholic liver
injury was recently investigated in hepatocyte-specific STAT3
knockout (H-STAT3KO) mice and macrophage/neutrophil-
specific STAT3 KO (M/N-STAT3KO) and endothelial STAT3
mice [84]. Compared with wild-typemice, Kupﬀer cells from
alcohol-fed hepatocyte-specific STAT3KO mice produced
similar amounts of ROS and hepatic proinflammatory
cytokines compared to control mice [85]. On the other hand,
Kupﬀer cells from M/N-STAT3KO mice produced higher
ROS and TNFα compared with wild-type controls. These
results suggest that STAT3 in hepatocytes promotes ROS
production and inflammation whereas myeloid cell STAT3
reduces ROS and hepatic inflammation during alcoholic liver
injury [85]. Thus, STAT3 may regulate hepatic inflammatory
cytokines via ROS production.
5. Stress and Immune Signaling:
How Are They Linked in ALD?
Cellular stress responses during alcohol exposure include
oxidative stress due to metabolism of alcohol in the liver,
ER stress, mitochondrial imbalance, heat shock protein
induction, and inflammatory processes. Numerous mouse
models have been used to study the discrete role of each
of the stress responses in alcohol-mediated liver pathology.
Yet, accumulating evidence suggests that these pathways
cannot be regarded separately and are tightly interrelated.
Similar to other inflammatory diseases [86], alcoholic liver
disease is multifactorial and it is important to take into
account interactions between various cellular responses
for a better understanding of the pathogenesis of ALD.
Based on studies so far, a clear relationship between
oxidative stress and inflammation is emerging in ALD. It
is increasingly apparent that in addition to gut-derived
endotoxin, alcohol-induced upregulation of oxidative stress
mediators plays a major part in activation of receptors,
intracellular kinases, and transcription factors in innate
immune cells (Figure 1). Pathways described above that
are interrelated in ALD include ROS-mediated activation
of TLR4 in macrophages, mitochondrial ROS regulation
of transcriptional activators such as PGC-1α and HIF-1α
promoting TNFα induction, ROS and autophagy associated
enhancement of proinflammatory cytokine production [86],
ER stress-associated innate immune cell activation, hsp-
mediated activation of proinflammatory signaling kinases,
and finally direct activation of transcription factors such as
NFκB and STAT3 by ROS. Alcoholic liver disease exhibits
enhanced inflammatory responses and exaggerated TNFα
production leading to liver injury. While TNFRI knockout
mice are protected from alcohol-induced liver injury [87],
alcohol-induced ROS production was unaﬀected in TNFRI
knockout mice indicating that ROS predominantly serves
as a redox signal for proinflammatory cytokine production
and may not be a direct toxicant to hepatocytes [87]. These
studies argue against the direct role of ROS or oxidative stress
in alcoholic liver injury and in fact support the notion that
oxidative stress/ROS primarily aﬀects and is indispensable to
proinflammatory activation and cytokine induction in ALD
creating a vicious cycle of the two pathways (Figure 1). Thus,
attempts to further clarify the importance of oxidative stress
and its cross-talk with inflammatory pathways will provide
an insight into pathogenesis of ALD and open avenues for
novel therapeutic targets.
6. Conclusion
This paper clearly implicates the role of oxidative stress
in proinflammatory signaling and macrophage activation
during liver injury providing a feed-forward mechanism
in ALD. Therefore, targeting redox-sensitive inflammatory
pathways and transcription factors oﬀers great promise for
treatment of ALD. Investigation of agents that interfere with
oxidative stress mediators directly hampering inflammatory
cytokine production is needed. Whether these agents will
then alleviate alcoholic liver disease in patients should be
tested.
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